Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It is a once-weekly injection
Phase 2: Growing Scientific Interest Scientific attention surrounding retatrutide increased substantially following publication of its Phase 2 obesity trial in 2023
In preclinical models, co-administration of bimagrumab or dual myostatin/activin A inhibitors with GLP-1R agonists preserves or increases muscle mass while enhancing fat loss, resulting in improved body composition and metabolic outcomes compared with GLP-1R agonist monotherapy [176]
Choline aids in breaking down fat cells, which can be used as an energy source
US$ 20.05
US$ 21.19
US$ 25.20
US$ 27.41
